Infleqtion (INFQ) director receives 33,928 stock options at $12.59 strike

Rhea-AI Filing Summary

Infleqtion, Inc. director Dawn Clawson Meyerriecks received a grant of stock options as equity compensation. She was awarded 33,928 options to buy Infleqtion common stock at an exercise price of $12.59 per share, expiring on April 10, 2036. Following this grant, she holds 33,928 derivative securities linked to common stock.

The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting after April 10, 2026, subject to her continued service under the company’s 2026 Equity Incentive Plan and any acceleration provisions in the Non-Employee Director Compensation Policy.

Insights

Equity compensation analyst

Routine stock option grant to Infleqtion director as part of board compensation.

Director Dawn Clawson Meyerriecks received 33,928 stock options with a $12.59 exercise price, expiring on April 10, 2036. The filing classifies this as a grant or award acquisition rather than an open‑market trade, indicating standard equity-based compensation.

The options vest entirely on the earlier of May 23, 2027 or the next annual stockholder meeting after April 10, 2026, conditioned on continuous service and subject to possible acceleration under the non-employee director policy. With no sales reported, this appears to be a routine compensation event rather than a signal about the director’s view of the stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Meyerriecks Dawn Clawson

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	33,928	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 33,928 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 33,928 options Exercise price: $12.59 per share Expiration date: April 10, 2036 +3 more

6 metrics

Options granted 33,928 options Stock Option (Right to Buy) grant on April 10, 2026

Exercise price $12.59 per share Conversion or exercise price for granted options

Expiration date April 10, 2036 Option term end for granted stock options

Underlying shares 33,928 shares Infleqtion common stock underlying the options

Post-grant derivative holdings 33,928 derivative securities Total options held after the transaction

Vesting outside date May 23, 2027 Latest vesting date if no earlier annual meeting occurs

Key Terms

Stock Option (Right to Buy), 2026 Equity Incentive Plan, Non-Employee Director Compensation Policy, Continuous Service, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

2026 Equity Incentive Plan financial

"as defined in the Issuer's 2026 Equity Incentive Plan"

Non-Employee Director Compensation Policy financial

"contained in the Issuer's Non-Employee Director Compensation Policy"

Continuous Service financial

"subject to the Reporting Person's Continuous Service with the Issuer"

stock options financial

"The options vest in full on the earlier of (i) May 23, 2027"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meyerriecks Dawn Clawson

(Last) (First) (Middle)

C/O INFLEQTION, INC.

1315 WEST CENTURY DRIVE, SUITE 150

(Street)

LOUISVILLE COLORADO 80027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Infleqtion, Inc. [ INFQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$12.59	04/10/2026		A		33,928		(1)	04/10/2036	Common Stock	33,928	$0	33,928	D

Explanation of Responses:

1. The options vest in full on the earlier of (i) May 23, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders following April 10, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2026 Equity Incentive Plan) with the Issuer through such date. Vesting shall be subject to any acceleration provisions contained in the Issuer's Non-Employee Director Compensation Policy.

	/s/ Jason D. Hall, Attorney-in-Fact	04/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Infleqtion (INFQ) director Dawn Clawson Meyerriecks report on this Form 4?

She reported receiving a grant of 33,928 stock options for Infleqtion common stock. These options are compensation, not an open-market purchase, and give her the right to buy shares at a fixed exercise price in the future if vesting conditions are met.

What are the key terms of the Infleqtion (INFQ) stock options granted to the director?

The director received 33,928 options with an exercise price of $12.59 per share and an expiration date of April 10, 2036. Each option is linked to one share of Infleqtion common stock, aligning director incentives with long-term shareholder value.

When do the new Infleqtion (INFQ) stock options for the director vest?

The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual meeting of stockholders after April 10, 2026. Vesting requires continuous service and may accelerate under the non-employee director compensation policy.

How many Infleqtion (INFQ) derivative securities does the director hold after this transaction?

After the grant, the director holds 33,928 derivative securities in the form of stock options. This figure reflects her option position reported in the filing and shows the equity-linked portion of her compensation tied to Infleqtion’s common stock.

Is the Infleqtion (INFQ) Form 4 a buy or sell signal for investors?

The Form 4 shows a grant of options, not a market purchase or sale. It records standard equity compensation for a director, classified as a grant or award acquisition, so it mainly reflects governance and incentive alignment rather than a trading decision.

What company plans or policies govern the Infleqtion (INFQ) option grant to the director?

The grant is issued under Infleqtion’s 2026 Equity Incentive Plan and is subject to the Non-Employee Director Compensation Policy. These documents define vesting conditions, acceleration provisions, and overall structure of equity awards for non-employee directors.